Japan

The Japanese Pharma Market

Japan continues to be one of the largest pharmaceutical markets in the world, making up approximately 7% of the global share. Historically, Japan has been viewed as insular compared to other developed markets such as Europe or the US, with foreign companies reporting high barriers to entry.

Rentschler Biopharma Extends Japanese Pact

German biopharmaceuticals contract development and manufacturing organization Rentschler Biopharma is extending and deepening its existing collaboration in Japan with Summit Pharmaceuticals International (SPI), a wholly owned subsidiary of Sumitomo.

Japan’s Changing Pharmaceutical Landscape

Role Reversal

Heavy Reliance on Contract Manufacturing

Leaving the Patent Cliff Behind

Significant Value Creation

BASF Adds Medical Grade Plastics Team in Japan

Evonik Expands Specialty Silica Capacities in Japan

Bioplastics Commercialization in Asia

Japan's Idemitsu to Proceed with $9 Billion Vietnam Refinery Project

The Japanese Economy Expects a Big Boost to FY13 Growth from Policy Effects

Realignment of the Pharmaceutical Supply Chain in Japan

GSK Raises Bet on AIDS Drug with New Shionogi Deal

World Diaper Output May Take a Hit from Blasts at Japan Plant

Japan's Asahi Kasei to buy U.S. Zoll for $2.2 Billion

UN Atom Chief Yukiya Amano Urges Nuclear Safety Inspections, Tests

Banri Kaieda: Japan Economy Will Suffer If Nuclear Power Axed

Japan May Crude, LNG Imports Jump On Nuclear Shutdowns

Asia’s Future Bioplastics Hub

Japan Nuclear Operator Aims for Cold Shutdown in 6-9 Months

Japan March Petchem Naphtha Imports Fall 10% Year over Year

World Health Organization: Japan Nuclear Accident No Worse

Russia Set To Double Oil Supply To Japan

Guenther Oettinger Plays Down Japan Warning

Fukushima Daiichi: Dangers Posed By Japan's Quake-Hit Nuclear Plant

Japan Quake: Dow Chemical Facility Flooded, DuPont Reporting Minor Damage

Japan's Maruzen Shuts 2 Group Crackers After Quake

Kansai Paint Accuses South Africa's Freeworld of Obstructing Takeover Bid

Otsuka Up 5% in Tokyo Debut after $2.4 Billion IPO

Punching above its weight

Mitsubishi Chemicals, Asahi Kasei JV Starts April 2011

Glaxo Seeks Out Japanese Partnerships

Mitsui Chem to Restart Naphtha Cracker Late March